Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

JETS vs ARKG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

JETS Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

JETS Overall Winner 6-Pillar Tally: JETS 0 – 0 ARKG (6 Tie) Matrix Metrics: JETS 2 – 1 ARKG

As of Nov 16, 2026, U.S. Global Jets ETF (JETS) is the stronger overall head-to-head candidate over ARK Genomic Revolution ETF (ARKG) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). JETS carries a Unified Composite Score of 41.5/100 (SELL) at $28.98 (N/M Forward P/E, N/A operating margin), whereas ARKG carries 48.6/100 (HOLD) at $40.92 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While ARKG currently prints a higher short-term Unified Composite Score (48.6/100 HOLD vs. JETS 41.5/100 SELL), JETS captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About JETS vs ARKG
JETS NYSE Arca Head-to-Head Winner
U.S. Global Jets ETF
Institutional Equity
$28.98
+0.5% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.51β · 42% Vol
Unified Composite Score
41.5 / 100 SELL
Tech 20.0 Fund 34.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 54
RSI-14: 54.0 · SMA20: $27.99 · SMA50: $27.88
ARKG Cboe BZX
ARK Genomic Revolution ETF
Institutional Equity
$40.92
-5.28% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.08β · 70% Vol
Unified Composite Score
48.6 / 100 HOLD
Tech 26.0 Fund 45.0 Flow 50.0 Mom 68.9
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 35
RSI-14: 35.2 · SMA20: $48.17 · SMA50: $49.46

6-Pillar Scorecard Institutional Category Breakdown (JETS 0 – 0 ARKG)

Columns: Metric · JETS · ARKG
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 26.4% (32nd %ile) 47.2% (38th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: JETS (2) vs ARKG (1)
Institutional Metric JETS ARKG Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
52% ($24–$34) 48% ($25–$59) Stronger Trend JETS
Beta / 30D Volatility
Risk Regime
1.51β · 42% Vol 2.08β · 70% Vol Lower Realized Risk JETS
Unified Institutional Score
Composite Signal
41.5 / 100 (SELL) 48.6 / 100 (HOLD) Higher Composite ARKG
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon JETS +24.51 pp
JETS: +12.13% · ARKG: -12.38%
3M Horizon JETS +0.9 pp
JETS: -4.4% · ARKG: -5.3%
6M Horizon ARKG +32.13 pp
JETS: +13.44% · ARKG: +45.57%
1Y Horizon ARKG +36.22 pp
JETS: +15.11% · ARKG: +51.33%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JETS vs ARKG. Trailing 12-month operating profitability (JETS N/A vs ARKG N/A) and valuation multiples (JETS N/M vs ARKG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

JETS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
ARKG ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
JETS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 26.4%
IV Percentile 32nd %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact JETS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ARKG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 47.2%
IV Percentile 38th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ARKG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
JETS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ARKG Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ JETS vs ARKG Key Questions & Quantitative Answers

As of Nov 16, 2026, U.S. Global Jets ETF (JETS) is the stronger overall head-to-head candidate over ARK Genomic Revolution ETF (ARKG) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). JETS carries a Unified Composite Score of 41.5/100 (SELL) at $28.98 (N/M Forward P/E, N/A operating margin), whereas ARKG carries 48.6/100 (HOLD) at $40.92 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While ARKG currently prints a higher short-term Unified Composite Score (48.6/100 HOLD vs. JETS 41.5/100 SELL), JETS captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

JETS and ARKG split Growth & Scale metrics: JETS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ARKG at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, JETS generates N/A in USD-normalized revenue versus N/A for ARKG. In operating R&D and SG&A reinvestment, JETS deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ARKG.

JETS and ARKG trade at balanced relative valuation multiples. JETS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ARKG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JETS (N/A ROE) versus ARKG (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, JETS carries 26.4% implied volatility (32nd %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.51β · 42% Vol realized risk). By comparison, ARKG carries 47.2% implied volatility (38th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.08β · 70% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.